Sandbox:Javaria: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref><ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid12484692">{{cite journal |vauthors=Bazemore AW, Smucker DR |title=Lymphadenopathy and malignancy |journal=Am Fam Physician |volume=66 |issue=11 |pages=2103–10 |date=December 2002 |pmid=12484692 |doi= |url=}}</ref><ref name="pmid10549745">{{cite journal |vauthors=Soldes OS, Younger JG, Hirschl RB |title=Predictors of malignancy in childhood peripheral lymphadenopathy |journal=J. Pediatr. Surg. |volume=34 |issue=10 |pages=1447–52 |date=October 1999 |pmid=10549745 |doi=10.1016/s0022-3468(99)90101-x |url=}}</ref><ref name="pmid10189390">{{cite journal |vauthors=Ghirardelli ML, Jemos V, Gobbi PG |title=Diagnostic approach to lymph node enlargement |journal=Haematologica |volume=84 |issue=3 |pages=242–7 |date=March 1999 |pmid=10189390 |doi= |url=}}</ref>
<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref><ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid12484692">{{cite journal |vauthors=Bazemore AW, Smucker DR |title=Lymphadenopathy and malignancy |journal=Am Fam Physician |volume=66 |issue=11 |pages=2103–10 |date=December 2002 |pmid=12484692 |doi= |url=}}</ref><ref name="pmid10549745">{{cite journal |vauthors=Soldes OS, Younger JG, Hirschl RB |title=Predictors of malignancy in childhood peripheral lymphadenopathy |journal=J. Pediatr. Surg. |volume=34 |issue=10 |pages=1447–52 |date=October 1999 |pmid=10549745 |doi=10.1016/s0022-3468(99)90101-x |url=}}</ref><ref name="pmid10189390">{{cite journal |vauthors=Ghirardelli ML, Jemos V, Gobbi PG |title=Diagnostic approach to lymph node enlargement |journal=Haematologica |volume=84 |issue=3 |pages=242–7 |date=March 1999 |pmid=10189390 |doi= |url=}}</ref>
{{familytree/start |summary=Management of lymphadenopathy}}
{{familytree/start |summary=Management of lymphadenopathy}}
{{familytree | | | | | | | | | Z01 | | | | | | | |Z01='''History'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br><div style="float: left; text-align: left; width: 20em; padding:1em;">
{{familytree | | | | | | | | | | Z01 | | | | | | | |Z01='''History'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br><div style="float: left; text-align: left; width: 20em; padding:1em;">
:❑[[Patient]] [[age]] (specific demographic characteristics ([[age]]) of certain [[malignancy|malignancies]])<br>
:❑[[Patient]] [[age]] (specific demographic characteristics ([[age]]) of certain [[malignancy|malignancies]])<br>
:❑ Duration of [[lymphadenopathy]] (<2 weeks or >1 year without an increase in size has low malignant potential)<br>
:❑ Duration of [[lymphadenopathy]] (<2 weeks or >1 year without an increase in size has low malignant potential)<br>
Line 11: Line 11:
:❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)<br>
:❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)<br>
:❑ Associated symptoms such as [[pain]], [[fever]], [[weight loss]], [[anorexia]], [[cough]], or recurrent [[UTI]]s}}
:❑ Associated symptoms such as [[pain]], [[fever]], [[weight loss]], [[anorexia]], [[cough]], or recurrent [[UTI]]s}}
{{familytree | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | M01 | | | | | | | M01='''[[Physical exam]]'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br>'''Appearance of the [[patient]]'''<br>[[Cachexia]] or surgical scar marks demonstrating previous malignancy treatment<br>
{{familytree | | | | | | | | | | M01 | | | | | | | M01='''[[Physical exam]]'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br>'''Appearance of the [[patient]]'''<br>[[Cachexia]] or surgical scar marks demonstrating previous malignancy treatment<br>
❑ [[Vital signs]]<br>
❑ [[Vital signs]]<br>
:❑ [[Temperature]]: High-grade / low-grade fever may demonstrate [[infection]]. <br>
:❑ [[Temperature]]: High-grade / low-grade fever may demonstrate [[infection]]. <br>
Line 26: Line 26:
❑ [[Limb (anatomy)|Extremities]] exam<br>
❑ [[Limb (anatomy)|Extremities]] exam<br>
❑ Skin exam: Evaluate for the lesions that indicate [[malignancy]] such as [[melanoma]]/ potential inoculation sites for germ such as traumatic lesions.}}
❑ Skin exam: Evaluate for the lesions that indicate [[malignancy]] such as [[melanoma]]/ potential inoculation sites for germ such as traumatic lesions.}}
{{familytree | | | | | | | | | |!| | | | | | |}}
{{familytree | | | | | | | | | | |!| | | | | | |}}
{{familytree | | | | | | | | | N01 | | | | | | | N01='''Palpable [[lymph node]]'''<div style="float: left; text-align: left; width: 20em; padding:1em;"><div class="mw-collapsible mw-collapsed"><br>
{{familytree | | | | | | | | | | N01 | | | | | | | N01='''Palpable [[lymph node]]'''<div style="float: left; text-align: left; width: 20em; padding:1em;"><div class="mw-collapsible mw-collapsed"><br>
❑ Location: (Localized vs generalized)<br>
❑ Location: (Localized vs generalized)<br>
:❑ For nodes involving several groups of nodes; suspect malignancy.<br>
:❑ For nodes involving several groups of nodes; suspect malignancy.<br>
Line 35: Line 35:
:❑ Right [[supraclavicular lymph nodes|supraclavicular L.N]], suspect intra-thoracic carcinoma<br>
:❑ Right [[supraclavicular lymph nodes|supraclavicular L.N]], suspect intra-thoracic carcinoma<br>
❑ Dimensions <br>
❑ Dimensions <br>
The aforementioned dimensions are abnormal for a palpable [[lymph node]] but do not lead to the suspician of a [[neoplasm]].
The aforementioned dimensions are abnormal for a palpable [[lymph node]] but do not lead to the suspicion of a [[neoplasm]].
:❑ [[Supraclavicular lymph nodes|supraclavicular]], [[iliac lymph nodes|iliac]], [[epitrochlear lymph nodes|epitrochlear]], and [[popliteal lymph nodes]] >0.5cm <br>
:❑ [[Supraclavicular lymph nodes|supraclavicular]], [[iliac lymph nodes|iliac]], [[epitrochlear lymph nodes|epitrochlear]], and [[popliteal lymph nodes]] >0.5cm <br>
:❑ [[Inguinal nodes]] > 1.5 cm <br>
:❑ [[Inguinal nodes]] > 1.5 cm <br>
Line 52: Line 52:
:❑ Fixed [[Lymph node|L.N]] to surrounding tissue; suspect [[malignancy]]}}.
:❑ Fixed [[Lymph node|L.N]] to surrounding tissue; suspect [[malignancy]]}}.
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | |,|-|-|-|v|-|-|-|+|-|-|-|-|.| | |}}
{{familytree | | | | | | | | | | U01 | | | | | | | U01='''Labs'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;">
{{familytree | | Y01 | | Y02 | | Y03 | | | Y04 | | | |Y01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Diagnostic''' of benign disease|Y02='''Suggests [[autoimmune]] infection'''|Y03='''Suggests malignancy'''|Y04='''unexplained'''}}
❑ [[CBC]] with differential<br>
{{familytree | | | | | | | |!| | |!| | | | | |}}
❑ [[ESR]]<br>
{{familytree | | | | | | | | |,|-|-| K01 | |!| | | | | | |K01=<div style="float: left; text-align: left; width: 20em; padding:1em;">}}
❑ [[CMP]]<br>
{{familytree | | | | | | | | |!| | |!| | | |!| | | | | |}}
❑ [[Peripheral smaer]]<br>
{{familytree | | | | | X01 | |`|-|-|v|'| | | | | | |X01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'❑ }}
❑ [[Liver function tests|LFTs]]}}
{{familytree | | | | | |!| | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | W01 | | | | |!| | | | | | | |W01=<div style="float: left; text-align: left; width: 20em; padding:1em;">}}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | |,|-|-|-|v|-|-|-|-|+|-|-|-|-|.| | |}}
{{familytree | Y01 | | Y02 | |,| Y03 | | | Y04 | | | |Y01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Diagnostic of self-limiting or benign disease'''<br>
[[Pharyngitis]], [[URTI]], [[conjunctivitis]], [[cat-scratch disease]], etc|Y02='''Suggests infection/ serious infection'''|Y03='''unexplained'''|Y04='''Suggests malignancy'''}}
{{familytree | |!| | | |!| | |!|!| | | | |!|}}
{{familytree | K01 | | K02 | |!| K03 | | | | |!| | K01=<div style="float: left; text-align: left; width: 20em; padding:1em;"> May require specific tests<div class="mw-collapsible mw-collapsed"><br>
❑ Throat swab<br>
❑ [[Sputum exam]]| K02=<div style="float: left; text-align: left; width: 20em; padding:1em;">Perform specific tests<div class="mw-collapsible mw-collapsed"><br>
❑ [[Mononucleosis|IM]]: [[Mononucleosis laboratory findings|Heterophile Antibody]] and [[Mononucleosis laboratory findings|monospot test]] <br>
❑ [[Syphilis]]: [[VDRL]], [[RPR]]<br>
❑ [[HIV]]: [[HIV test#Antibody tests|HIV antibody test]] <br>
❑ [[CMV]]: Anti CMV [[IgM]]<br>
❑ [[Autoimmune disorders]]: [[ANA]], [[Rheumatoid factor]], etc<br>
❑ [[Tuberculosis]]: [[PPD]]<br>
❑ [[Cat scratch fever|Cat scratch disease]]: [[IgM]], [[IgG]]|K03=Positive}}
{{familytree | |!| | | |!| | |!| | | | | |!|}}
{{familytree | |!| | |,|^|-|.|!| | | | |!|}}
{{familytree | |!| | B01 | | B02 | | | | | | |!| |B01=Positive|B02=Negative}}
{{familytree | |!| | |!| | | | | | | | |!| | | | | |W01=Positive}}
{{familytree | |!| | |!| | | | | | |!| | | |X02=}}
{{familytree | |!| | |!| | | | | | |!| | |,|-|^|-|.|}}
{{familytree | W01 | | W02 | | | | | |!| | | | | | | |W01=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ Treat<div class="mw-collapsible mw-collapsed">with [[antibiotics]] if required and/ or symptomatic treatment<br>
❑ For an untreatable or disease with residual symptoms counsel the [[patient]]<br>
❑ Follow up for advancing or persistent [[lymphadenopathy|LAD]]|W02=<div style="float: left; text-align: left; width: 20em; padding:1em;">Treat<div class="mw-collapsible mw-collapsed"><br>
❑ [[Mononucleosis medical therapy|IM treatment]]<br>
❑ [[Syphilis medical therapy|Syphilis treatment]]<br>
❑ [[HIV medical therapy|HIV treatment]]<br>
❑ [[Cytomegalovirus infection medical therapy|CMV treatment]]<br>
❑ [[Autoimmunity#Treatments|Treatment of autoimmune disorders]]<br>
❑ [[Tuberculosis medical therapy|Tuberculosis treatment]]<br>
❑ [[Cat scratch fever medical therapy|cat scratch disease treatment]]}}
{{familytree | | | | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; padding:1em;">}}
{{familytree | | | | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; padding:1em;">}}
{{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | }}
{{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | }}
{{familytree | | | | | | W01 | | | | | W02 | | | | | | |W01='''Patient is unstable''' <br> |W02='''Patient is stable'''}}
{{familytree | | | | | | W01 | | | | | W02 | | | | | | |W01= <br> |W02='}}
{{familytree | | | | | |!| | | | | | |!| | | | }}
{{familytree | | | | | |!| | | | | | |!| | | | }}
{{familytree | | | | | L01 | | | | | |!| | | | L01=<div style="float: left; text-align: left; line-height: 150% ">}}
{{familytree | | | | | L01 | | | | | |!| | | | L01=<div style="float: left; text-align: left; line-height: 150% ">}}

Revision as of 00:46, 22 August 2020

[1][2][3][4][5]

.
 
 
 
 
 
 
 
 
 
History

Patient age (specific demographic characteristics (age) of certain malignancies)
❑ Duration of lymphadenopathy (<2 weeks or >1 year without an increase in size has low malignant potential)
❑ Past medical history of underlying disease, suggestive of immunodeficiency, or recurrent infections
❑ Sexual history suggestive of infection transmission
❑ Family history of certain malignant disorders (breast cancer, or melanoma)
❑ Exposure to communicable infectious diseases/ travel to high-risk areas
❑ Environmental exposure such as UV (skin cancer risk)/ animals/ occupational exposure
❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)
❑ Associated symptoms such as pain, fever, weight loss, anorexia, cough, or recurrent UTIs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physical exam

Appearance of the patient
Cachexia or surgical scar marks demonstrating previous malignancy treatment

Vital signs

Temperature: High-grade / low-grade fever may demonstrate infection.
Heart rate: Tachycardia with regular pulse may demonstrate infection.
Respiratory rate: Tachypnea may demonstrate respiratory system involvement (infection\ metastasis).
Blood pressure: Chronic hypertension or hypotension (may indicate sepsis as a complication).
Oxygen saturation: may be low if the respiratory system is affected.

❑ HEENT
Cardiovascular examination
Respiratory examination
Gastrointestinal system exam includes oral examination, abdominal examination, and digital rectal exam.

Splenomegaly) may demonstrate IM, hodgkin's/ non-Hodgkin's lymphoma, and sarcoidosis

Extremities exam

❑ Skin exam: Evaluate for the lesions that indicate malignancy such as melanoma/ potential inoculation sites for germ such as traumatic lesions.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palpable lymph node

❑ Location: (Localized vs generalized)

❑ For nodes involving several groups of nodes; suspect malignancy.
❑ An enlarged node in a lymphatic rich region; suspect local disease.
❑ Associated red streaking, suspect lymphangitis.
❑ Left supraclavicular L.N (Virchow's nodes); suspect gastric carcinoma
❑ Right supraclavicular L.N, suspect intra-thoracic carcinoma

❑ Dimensions
The aforementioned dimensions are abnormal for a palpable lymph node but do not lead to the suspicion of a neoplasm.

supraclavicular, iliac, epitrochlear, and popliteal lymph nodes >0.5cm
Inguinal nodes > 1.5 cm
❑ Other area lymph nodes >1 cm

❑ Tenderness or pain:

❑ Suspect infection.
❑ A neoplastic node may also demonstrate pain due to hemorrhage associated with central necrosis or a brisk growing tumor.

❑ Consistency

❑ Hard on palpation; suspect chronic inflammation
❑ consistent- acute inflammation
❑ Stony-hard and painless nodes-metastatic cancer/ granuloma
❑ Firm and rubbery nodes- lymphoma
❑ Matted L.N suspect mycobacterium / sarcoidosis/ lymphoma / metastatic carcinoma)

❑ Mobility

❑ Freely movable; suspect infections and collagen vascular disease
❑ Fixed L.N to surrounding tissue; suspect malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Labs

CBC with differential
ESR
CMP
Peripheral smaer

LFTs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic of self-limiting or benign disease
Pharyngitis, URTI, conjunctivitis, cat-scratch disease, etc
 
Suggests infection/ serious infection
 
 
 
unexplained
 
 
Suggests malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
May require specific tests

❑ Throat swab

Sputum exam
 
 
 
 
Positive
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive
 
Negative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Treat
with antibiotics if required and/ or symptomatic treatment

❑ For an untreatable or disease with residual symptoms counsel the patient

❑ Follow up for advancing or persistent LAD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
'
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1. Garg PK, Jain BK, Dubey IB, Sharma AK (2013). "Generalized lymphadenopathy: physical examination revisited". Ann Saudi Med. 33 (3): 298–300. doi:10.5144/0256-4947.2012.01.7.1525. PMC 6078537. PMID 22750769.
  2. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  3. Bazemore AW, Smucker DR (December 2002). "Lymphadenopathy and malignancy". Am Fam Physician. 66 (11): 2103–10. PMID 12484692.
  4. Soldes OS, Younger JG, Hirschl RB (October 1999). "Predictors of malignancy in childhood peripheral lymphadenopathy". J. Pediatr. Surg. 34 (10): 1447–52. doi:10.1016/s0022-3468(99)90101-x. PMID 10549745.
  5. Ghirardelli ML, Jemos V, Gobbi PG (March 1999). "Diagnostic approach to lymph node enlargement". Haematologica. 84 (3): 242–7. PMID 10189390.